Emcure Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Emcure Pharma	Gland Pharma	Pfizer
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	2.8 %	n/a	4.1 %
US DMF Filings	102.0 .	68.0 .	n/a
R&D as a % of Total Sales	3.9 %	5.4 %	n/a
Financials
5 yr Average ROE	20.81 %	12.02 %	19.03 %
5yr average Equity Multiplier	2.6	1.15	1.25
5yr Average Asset Turnover Ratio	0.93	0.51	0.6
5yr Avg Net Profit Margin	8.56 %	20.79 %	26.04 %
Price to Book	5.73	3.1	6.12
P/E	31.26	35.03	27.57
5yr Avg Cash Conversion Cycle	-8.5 Days	69.81 Days	21.86 Days
Inventory Days	82.11 Days	118.26 Days	49.93 Days
Days Receivable	87.83 Days	99.92 Days	29.1 Days
Days Payable	177.06 Days	107.43 Days	77.28 Days
5yr Average Interest Coverage Ratio	5.19	183.05	185.18
5yr Avg ROCE	27.53 %	16.55 %	23.84 %
5yr Avg Operating Profit Margin	19.97 %	29.26 %	31.72 %
5 yr average Debt to Equity	0.76	0.01	0.0
5yr CAGR Net Profit	11.68 %	-6.87 %	76.68 %
5yr Average Return on Assets	7.99 %	10.65 %	15.25 %
Shareholdings
Promoter Holding	77.87 %	51.83 %	63.92 %
Share Pledged by Promoters	0.04 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.21 %	-6.03 %	0.0
Change in Mutual Fund Holding (3 Yrs)	1.53 %	11.93 %	5.74 %

Business

	Emcure Pharma	Gland Pharma	Pfizer
Product Wise Break-Up	Product Wise Break-Up Formulations 95.73 API`s 4.27 Injectables 0 Pharmaceuticals 0 Pharmaceutical 0	Product Wise Break-Up Injectables 0 Pharmaceutical 100.0 API`s 0 Formulations 0 Pharmaceutical 0	Product Wise Break-Up Injectables 0 Pharmaceuticals 0 API`s 0 Formulations 0 Pharmaceutical 100.0
Product Wise Break-Up	Product Wise Break-Up Formulations 95.73 API`s 4.27 Injectables 0 Pharmaceuticals 0 Pharmaceutical 0	Product Wise Break-Up Injectables 0 Pharmaceutical 100.0 API`s 0 Formulations 0 Pharmaceutical 0	Product Wise Break-Up Injectables 0 Pharmaceuticals 0 API`s 0 Formulations 0 Pharmaceutical 100.0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Cardiovascular 20.8 Gynecology 18.5 Anti-infectives 12.8 Pain and analgesics 7.1 Vitamins, minerals and nutrients 6.7 Blood-related 5.9 Oncology/Anti-neoplastics 5.4 Respiratory 5.1 HIV antivirals 4.5 Gastrointestinal 3.7 Anti-diabetic 2.9 Neurology/CNS 1.6 Hormones 0 Others 5.0	-	-
Location Wise Break-Up	Location Wise Break-Up India 45.42 Other continents 19.65 Europe 19.56 North America 15.33 Canada, Australia & New Zealand 0 Australia 0 Canada 0 USA 0 Rest of the World 0 Others 0.04	Location Wise Break-Up Rest of the World 0 North America 0 Other continents 0 Europe 19.15 Canada 0 India 4.47 USA 55.68 Australia 0 Canada, Australia & New Zealand 3.28 Others 17.42	Location Wise Break-Up Rest of the World 5.0 North America 0 Other continents 0 Europe 0 Canada 0 India 95.0 USA 0 Australia 0 Canada, Australia & New Zealand 0
Acute vs Chronic	Acute vs Chronic Chronic 52.87 Acute therapy 47.13	-	-
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise India 97.98 North America 1.24 Other continents 0.78 Europe 0	-	-

Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE